FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 137 filers reported holding FLEXION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $797,000 | -22.4% | 89,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,027,000 | +8.6% | 89,000 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $946,000 | -4.7% | 90,900 | +20.3% | 0.00% | 0.0% |
| Q2 2020 | $993,000 | +68.0% | 75,542 | +0.5% | 0.00% | 0.0% |
| Q1 2020 | $591,000 | -62.5% | 75,142 | -1.4% | 0.00% | 0.0% |
| Q4 2019 | $1,578,000 | +109.0% | 76,242 | +38.4% | 0.00% | 0.0% |
| Q3 2019 | $755,000 | +31.8% | 55,100 | +18.2% | 0.00% | 0.0% |
| Q2 2019 | $573,000 | -18.3% | 46,600 | -17.1% | 0.00% | 0.0% |
| Q1 2019 | $701,000 | +10.2% | 56,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $636,000 | -42.4% | 56,200 | -4.7% | 0.00% | 0.0% |
| Q3 2018 | $1,104,000 | -33.5% | 59,000 | -8.1% | 0.00% | -50.0% |
| Q2 2018 | $1,660,000 | +5.8% | 64,200 | -8.3% | 0.00% | 0.0% |
| Q1 2018 | $1,569,000 | – | 70,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |